Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: Influence of monoamine oxidase type A

Addiction Biology

Volumn 14, Issue 2, 2009, Pages 185-193

  Alves, Ema ^a,d   Summavielle, Teresa ^a,b   Alves, Cecília Juliana ^a   Custódio, José Barata Antunes ^c   Fernandes, Eduarda ^d   De Lourdes Bastos, Maria ^d   Tavares, Maria Amélia ^a,e   Carvalho, Félix ^d,f  

^a UNIVERSITY OF PORTO   (Portugal)

^b POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d Campus Universitário de Santiago   (Portugal)

^e Porto School of Nursing   (Portugal)

^f UNIVERSITY OF PORTO   (Portugal)

Author keywords

3,4 methylenedioxymethamphetamine; Brain mitochondria; Hyperthermia; Monoamine oxidase A; Neurotoxicity; Oxidative stress

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CLORGYLINE; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; PROTEIN SUBUNIT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BODY TEMPERATURE; BRAIN DAMAGE; BRAIN MITOCHONDRION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HYPERTHERMIA; LIPID OXIDATION; MALE; MITOCHONDRIAL RESPIRATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RESPIRATORY CHAIN; SINGLE DRUG DOSE; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BRAIN; HALLUCINOGENS; LIPID PEROXIDATION; MITOCHONDRIA; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 61849137910     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2008.00143.x     Document Type: Article

References (40)

1. Alves E, Summavielle T, Alves CJ, Gomes-da-Silva J, Barata JC, Fernandes E, Bastos Mde L, Tavares MA, Carvalho F (2007) Monoamine oxidase-b mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria. J Neurosci 27 : 10203 10210.
2. Armstrong SC, Cozza KL (2002) Triptans. Psychosomatics 43 : 502 504.
3. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52 : 302 310.
4. Capela JP, Meisel A, Abreu AR, Branco PS, Ferreira LM, Lobo AM, Remiao F, Bastos ML, Carvalho F (2006a) Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J Pharmacol Exp Ther 316 : 53 61.
5. Capela JP, Ruscher K, Lautenschlager M, Freyer D, Dirnagl U, Gaio AR, Bastos ML, Meisel A, Carvalho F (2006b) Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience 139 : 1069 1081.
6. Carvalho M, Carvalho F, Remiao F, de Lourdes Pereira M, Pires-das-Neves R, de Lourdes Bastos M (2002) Effect of 3,4-methylenedioxymethamphetamine ('ecstasy') on body temperature and liver antioxidant status in mice: influence of ambient temperature. Arch Toxicol 76 : 166 172.
7. Chimenti F, Cottiglia F, Bonsignore L, Casu L, Casu M, Floris C, Secci D, Bolasco A, Chimenti P, Granese A, Befani O, Turini P, Alcaro S, Ortuso F, Trombetta G, Loizzo A, Guarino I (2006) Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and computational study. J Nat Prod 69 : 945 949.
8. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP (1996b) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379 : 733 736.
9. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor R, Schlyer D, Zezulkova I, Wolf AP (1996a) Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93 : 14065 14069.
10. Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177 : 751 766.
11. Han XH, Hong SS, Hwang JS, Lee MK, Hwang BY, Ro JS (2007) Monoamine oxidase inhibitory components from Cayratia japonica. Arch Pharm Res 30 : 13 17.
12. Hewton R, Salem A, Irvine RJ (2007) Potentiation of 3,4- methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor. Clin Exp Pharmacol Physiol 34 : 1051 1057.
13. Huether G, Zhou D, Ruther E (1997) Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4- methylenedioxymethamphetamine (MDMA, 'ecstasy') and its congeners. J Neural Transm 104 : 771 794.
14. Izumi T, Iwamoto N, Kitaichi Y, Kato A, Inoue T, Koyama T (2007) Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats. Eur J Pharmacol 565 : 105 112.
15. Khalil AA, Steyn S, Castagnoli N Jr. (2000) Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves. Chem Res Toxicol 13 : 31 35.
16. Kong LD, Cheng CH, Tan RX (2004) Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. J Ethnopharmacol 91 : 351 355.
17. Kort WJ, Hekking-Weijma JM, TenKate MT, Sorm V, VanStrik R (1998) A microchip implant system as a method to determine body temperature of terminally ill rats and mice. Lab Anim 32 : 260 269.
18. Malberg JE, Seiden LS (1998) Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18 : 5086 5094.
19. Morgan MJ (2000) Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berl) 152 : 230 248.
20. Morton J (2005) Ecstasy: pharmacology and neurotoxicity. Curr Opin Pharmacol 5 : 79 86.
21. Parrott AC (2002) Recreational Ecstasy/MDMA, the serotonin syndrome and serotonergic neurotoxicity. Pharmacol Biochem Behav 71 : 837 844.
22. Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233 : 357 363.
23. Rohn TT, Hinds TR, Vincenzi FF (1993) Ion transport ATPases as targets for free radical damage. Protection by an aminosteroid of the Ca2+ pump ATPase and Na+/K+ pump ATPase of human red blood cell membranes. Biochem Pharmacol 46 : 525 534.
24. Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S (1987) Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J Cereb Blood Flow Metab 7 : 752 758.
25. Sanchez V, O'Shea E, Saadat KS, Elliott JM, Colado MI, Green AR (2004) Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones. J Psychopharmacol 18 : 412 416.
26. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240 : 1 7.
27. Shih JC, Grimsby J, Chen K (1999) Molecular biology of monoamine oxidase A and B: their role in the degradation of serotonin. In : HBaM G, ed. Serotoninergic Neurons and 5-HT Receptors in the SNC, pp. 655 670. Berlin : Springer.
28. Silins E, Copeland J, Dillon P (2007) Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. Aust N Z J Psychiatry 41 : 649 655.
29. Spanos LJ, Yamamoto BK (1989) Acute and subchronic effects of methylenedioxymethamphetamine [(+/-) MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav 32 : 835 840.
30. Sprague JE, Everman SL, Nichols DE (1998) An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 19 : 427 441.
31. Sprague JE, Nichols DE (1995) The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits. J Pharmacol Exp Ther 273 : 667 673.
32. Stanley N, Salem A, Irvine RJ (2007) The effects of co-administration of 3,4-methylenedioxymethamphetamine ('ecstasy') or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats. Neuroscience 146 : 321 329.
33. Suliman HB, Carraway MS, Piantadosi CA (2003) Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am J Respir Crit Care Med 167 : 570 579.
34. Suliman HB, Carraway MS, Velsor LW, Day BJ, Ghio AJ, Piantadosi CA (2002) Rapid mtDNA deletion by oxidants in rat liver mitochondria after hemin exposure. Free Radic Biol Med 32 : 246 256.
35. Tomić M, Tovilović G, Butorović B, Krstić D, Janković T, Aljancić I, Menković N (2005) Neuropharmacological evaluation of diethylether extract and xanthones of Gentiana kochiana. Pharmacol Biochem Behav 81 : 535 542.
36. Toth LA (2000) Defining the moribund condition as an experimental endpoint for animal research. ILAR J 41 : 72 79.
37. Vuori E, Henry JA, Ojanpera I, Nieminen R, Savolainen T, Wahlsten P, Jantti M (2003) Death following ingestion of MDMA (ecstasy) and moclobemide. Addiction 98 : 365 368.
38. Youdim MB, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7 : 295 309.
39. Zhuang Z, Hogan M, McCauley R (1988) The in vitro insertion of monoamine oxidase B into mitochondrial outer membranes. FEBS Lett 238 : 185 190.
40. Zhuang ZP, Marks B, McCauley RB (1992) The insertion of monoamine oxidase A into the outer membrane of rat liver mitochondria. J Biol Chem 267 : 591 596.